Crossmark

Validation of a B cell acute lymphoblastic leukemia xenograft rat model for integrated efficacy, pharmacokinetics and safety of CD19 CAR-T

Published Online: 2026-03-14

Published Print: 2026-07

Authors

Kim, Joo-Il

Park, Mi-Young

Kwon, Euna

Mashimo, Tomoji

Kang, Hyoung Jin

Kang, Byeong-Cheol https://orcid.org/0000-0002-9485-516X
Funding

Funding for this research was provided by:

National Research Foundation of Korea (2020R1A2C2013101)

Seoul National University
License Information

Text and Data Mining valid from 2026-03-14

Version of Record valid from 2026-03-14
More Information

Article History

Received: 4 December 2025

Revised: 28 January 2026

Accepted: 8 February 2026

First Online: 14 March 2026

Declarations

:

: Authors declare no conflict of interest.

: All experiments were approved by the Institutional Animal Care and Use Committee in Seoul National University Hospital (SNUH-IACUC) and animals were maintained in the facility accredited AAALAC International (#001169) in accordance with Guide for the Care and Use of Laboratory Animals 8th edition.

: Not applicable.

Document is current